Kim Tsuchimoto Insider Profile
11 Followers
Kim Tsuchimoto, Director at Monopar Therapeutics Inc, holds 7.40K shares in Monopar Therapeutics Inc (Ticker: MNPR), holds 582.00 shares in Raptor Pharmaceutical Corp. (Ticker: RPTP).
Kim Tsuchimoto Monopar Therapeutics Inc (MNPR)Director
Monopar Therapeutics Inc (MNPR)
Director
Ranked #103,290 out of 109,349 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-121.50%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Kim Tsuchimoto holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 20, 2019 - Dec 20, 2020
Return:-78.80%
The most profitable trade made by Kim Tsuchimoto
Kim Tsuchimoto's Trading History
Monopar Therapeutics Inc
Aug 27, 2026
Director
Uninformative Sell
455.57K
$520.09K
Raptor Pharmaceutical Corp.
Aug 31, 2012
―
Uninformative Sell
17.55K
$5.24K
List of latest transactions for each holding click on a transaction to see Kim Tsuchimoto's performance on stock
You May Also Like
Kim Tsuchimoto insider profile FAQ
What is the percentage of profitable transactions made by Kim Tsuchimoto?
The percentage of profitable transactions made by Kim Tsuchimoto is 0%.
What is the average return per transaction made by Kim Tsuchimoto?
The average return per transaction made by Kim Tsuchimoto is -121.50%.
What stocks does Kim Tsuchimoto hold?
Kim Tsuchimoto holds: MNPR, RPTP stocks.
What was Kim Tsuchimoto’s latest transaction?
Kim Tsuchimoto latest transaction was an Uninformative Sell of $455.57K.
What was Kim Tsuchimoto's most profitable transaction?
Kim Tsuchimoto’s most profitable transaction was an Informative Buy of MNPR stock on December 20, 2019. The return on the trade was -78.80%.
What is Kim Tsuchimoto's role in Monopar Therapeutics Inc?
Kim Tsuchimoto's role in Monopar Therapeutics Inc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.